Other Current Liabilities - AVROBIO Inc (NASDAQ:TECX) - Alpha Spread

AVROBIO Inc
NASDAQ:TECX

Watchlist Manager
AVROBIO Inc Logo
AVROBIO Inc
NASDAQ:TECX
Watchlist
Price: 19.14 USD 0.74%
Market Cap: 281.9m USD
Have any thoughts about
AVROBIO Inc?
Write Note

AVROBIO Inc
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

AVROBIO Inc
Other Current Liabilities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
AVROBIO Inc
NASDAQ:TECX
Other Current Liabilities
$2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Current Liabilities
$3.2B
CAGR 3-Years
95%
CAGR 5-Years
282%
CAGR 10-Years
29%
Amgen Inc
NASDAQ:AMGN
Other Current Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Current Liabilities
$279.3m
CAGR 3-Years
7%
CAGR 5-Years
33%
CAGR 10-Years
21%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Current Liabilities
$586m
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
24%

See Also

What is AVROBIO Inc's Other Current Liabilities?
Other Current Liabilities
2m USD

Based on the financial report for Dec 31, 2023, AVROBIO Inc's Other Current Liabilities amounts to 2m USD.

What is AVROBIO Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 1Y
-74%

Over the last year, the Other Current Liabilities growth was -74%.

Back to Top